Intrust Bank Na Cytokinetics Inc Transaction History

Intrust Bank Na

$1.19 Billion
Q3 2025

A detailed history of Intrust Bank Na transactions in Cytokinetics Inc stock. As of the latest transaction made, Intrust Bank Na holds 4,553 shares of CYTK stock, worth $302,774. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,553

Holding current value

$302,774

% of portfolio

0.02%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 10, 2025	BUY	$33.23 - $54.96 $151,296 - $250,232	4,553 New	4,553 $250,000
Q3 2022 Nov 09, 2022	BUY	$38.54 - $54.52 $160,442 - $226,966	4,163 New	4,163 $202,000

Others Institutions Holding CYTK

# of Institutions

399

Shares Held

130M

Call Options Held

3.75M

Put Options Held

1.13M

T. Rowe Price Investment Management, Inc. Baltimore, MD

17.6M
Shares

$1.17 Billion
0.37% of portfolio
Black Rock Inc. New York, NY

14.7M
Shares

$976 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.9M
Shares

$788 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.83M
Shares

$521 Million
0.05% of portfolio
State Street Corp Boston, MA

6.37M
Shares

$424 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $6.26B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.

Account